Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

As the U.S. stock market faces a sell-off driven by concerns over tariffs and economic uncertainty, investors are increasingly looking for opportunities that can offer resilience and potential growth.

MoonLake, a clinical-stage biopharma company developing immunology therapeutics, was created by an April 2022 merger with ...

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) is one of 1,068 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We ...

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

Guggenheim began coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

Benitec Biopharma Inc.’s BNTC share price has surged by 11.39%, which has investors questioning if this is right time to sell ...